Cosimo Damiano Altomare

25PUBLICATIONS
88CO-AUTHORS
Predictive and prognostic markersMolecular targetsPharmacogenomicsBiologically active moleculesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 16, 2026
Empagliflozin in Lafora disease: A first-in-human 6-month pilot study with electroclinical and FDG-PET findings.

|Sep 01, 2026
Identification of New Putative Autotaxin Inhibitors via Structure-Based Virtual Screening and Evaluation of Their Antiproliferative Properties Against Ovarian and Breast Cancer Cells.

|Aug 05, 2026
Sustained seizure reduction, treatment simplification, and high retention with cenobamate: A 12-month real-world study in refractory and ultra-refractory focal epilepsy.

|Oct 29, 2025
Investigating Amphoteric 3,4'-Biscoumarin-Based ortho-[(Dialkylamino)methyl]phenols as Dual MAO and ChE Inhibitors.

Anthi Petrou, Caterina Deruvo, Rosa Purgatorio

|May 23, 2025
Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets.

Giuseppe d'Orsi, Antonella Liantonio, Paola Imbrici

|Mar 28, 2025
Retrospective Clinical Investigation into the Association Between Abnormal Blood Clotting, Oral Anticoagulant Therapy, and Medium-Term Mortality in a Cohort of COVID-19 Patients.

Giorgia Dinoi, Maria Vittoria Togo, Pietro Guida

Pageof 5

Frequent Collaborators

14 joint publications

Marco Catto

13 joint publications

Modesto de Candia

12 joint publications

Rosa Purgatorio

6 joint publications

Orazio Nicolotti